Prolonged excess of glucocorticoids (GCs) has adverse systemic effects leading to
significant morbidities and an increase in mortality. Metabolic alterations associated with the …

Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …

Cushing's syndrome (CS), including visceral obesity, dyslipidemia, hypertension and
diabetes among its many manifestations, is “a model” of metabolic syndrome. Glucocorticoid …

An impaired glucose metabolism, which often leads to the onset of diabetes mellitus (DM), is
a common complication of chronic exposure to exogenous and endogenous glucocorticoid …

Diabetes mellitus is a frequent complication of Cushing syndrome (CS) which is caused by
chronic exposure to glucocorticoid excess, either endogenous or exogenous, and that is …

Recent evidence suggests that correction of hypercortisolism in Cushing's syndrome (CS)
may not lead to complete remission of the clinical abnormalities associated with this …

Cushing's syndrome is commonly complicated with an impairment of glucose metabolism,
which is often clinically manifested as diabetes mellitus. The development of diabetes …

Endogenous pathologic hypercortisolism, or Cushing's syndrome, is associated with poor
quality of life, morbidity, and increased mortality. Early diagnosis may mitigate against this …

Cushing's syndrome (CS) is a severe chronic and systemic condition caused by
endogenous or exogenous excess of glucocorticoids, associated with increased morbidity …

Although the concept of metabolic syndrome (MetS) as a disease entity continues to be
debated, it provides a means by which patients at risk for diabetes and cardiovascular …